Liam Ratcliffe Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Liam Ratcliffe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Liam Ratcliffe. Liam Ratcliffe is Director in ARRAY BIOPHARMA INC ($ARRY) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in Unum Therapeutics Inc. ($UMRX) and Director in Deciphera Pharmaceuticals, Inc. ($DCPH) and Director in ARVINAS INC. ($ARVN) and Director in Aptinyx Inc. ($APTX).
Latest Insider Trading Transactions of Liam Ratcliffe
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, ARRY, ARVN, COGT, DCPH, EDGE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21 2020 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Buy | P | 70.00 | 142,857 | 9,999,990 | 822,857 | 680 K to 822.9 K (+21.01 %) |
| Jun 04 2020 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Option Exercise | A | 33.57 | 12,000 | 402,840 | 12,000 | |
| May 27 2020 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Option Exercise | M | 22.06 | 6,500 | 143,390 | 6,423 | |
| May 27 2020 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Buy | M | 22.06 | 6,500 | 143,390 | 6,500 | 0 to 6.5 K |
| Nov 14 2019 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Buy | P | 22.00 | 680,000 | 14,960,000 | 680,000 | 0 to 680 K |
| Jun 18 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 2.43 | 7,881 | 19,151 | 7,881 | |
| May 28 2019 | ARVN | ARVINAS, INC. | Ratcliffe Liam | Director | Option Exercise | A | 22.06 | 12,923 | 285,081 | 12,923 | |
| Apr 03 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 4.40 | 4,829 | 21,248 | 4,829 | |
| Apr 02 2019 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Option Exercise | A | 4.05 | 4,123 | 16,698 | 4,123 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Ratcliffe Liam | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Ratcliffe Liam | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jan 04 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 4.47 | 4,860 | 21,724 | 4,860 | |
| Oct 03 2018 | ARVN | ARVINAS INC. | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 568,252 | 0 | 0 | |
| Oct 03 2018 | ARVN | ARVINAS INC. | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 3,601,657 | 0 | 0 | |
| Oct 03 2018 | ARVN | ARVINAS INC. | Ratcliffe Liam | Director | Buy | P | 16.00 | 375,000 | 6,000,000 | 375,000 | 0 to 375 K |
| Oct 03 2018 | ARVN | ARVINAS INC. | Ratcliffe Liam | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 1,908,048 | 1.3 M to 1.9 M (+48.71 %) |
| Oct 03 2018 | ARVN | ARVINAS INC. | Ratcliffe Liam | Director | Buy | C | 0.00 | 174,846 | 0 | 1,283,048 | 1.1 M to 1.3 M (+15.78 %) |
| Oct 03 2018 | ARVN | ARVINAS INC. | Ratcliffe Liam | Director | Buy | C | 0.00 | 1,108,202 | 0 | 1,108,202 | 0 to 1.1 M |
| Oct 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 10.37 | 2,111 | 21,891 | 2,111 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 14.57 | 1,504 | 21,913 | 1,504 | |
| Aug 15 2018 | EDGE | Edge Therapeutics, ... | Ratcliffe Liam | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 6,712,986 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 15,233,315 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 33,022,786 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 28,895,188 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Buy | P | 16.00 | 125,000 | 2,000,000 | 368,345 | 243.3 K to 368.3 K (+51.37 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Buy | P | 16.00 | 125,000 | 2,000,000 | 2,921,734 | 2.8 M to 2.9 M (+4.47 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Buy | C | 0.00 | 243,345 | 0 | 243,345 | 0 to 243.3 K |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Buy | C | 0.00 | 552,208 | 0 | 2,796,734 | 2.2 M to 2.8 M (+24.60 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Buy | C | 0.00 | 1,197,076 | 0 | 2,244,526 | 1 M to 2.2 M (+114.28 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Ratcliffe Liam | Director | Buy | C | 0.00 | 1,047,450 | 0 | 1,047,450 | 0 to 1 M |
| Jun 20 2018 | EDGE | Edge Therapeutics, ... | Ratcliffe Liam | Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 977,836 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 977,835 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Buy | P | 12.00 | 275,000 | 3,300,000 | 897,773 | 622.8 K to 897.8 K (+44.16 %) |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Buy | P | 12.00 | 275,000 | 3,300,000 | 897,772 | 622.8 K to 897.8 K (+44.16 %) |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 622,773 | 0 | 622,773 | 0 to 622.8 K |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 622,772 | 0 | 622,772 | 0 to 622.8 K |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 65,997 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 198,004 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 49,505 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 198,004 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 148,515 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | P | 17.00 | 375,000 | 6,375,000 | 2,146,308 | 1.8 M to 2.1 M (+21.17 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 372,883 | 0 | 1,771,308 | 1.4 M to 1.8 M (+26.66 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 1,118,722 | 0 | 1,398,425 | 279.7 K to 1.4 M (+399.97 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 279,703 | 0 | 279,703 | 0 to 279.7 K |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 1,118,722 | 0 | 1,957,832 | 839.1 K to 2 M (+133.32 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 839,110 | 0 | 839,110 | 0 to 839.1 K |
| Jun 21 2017 | EDGE | Edge Therapeutics, ... | Ratcliffe Liam | Director | Option Exercise | A | 10.15 | 15,000 | 152,250 | 15,000 | |
| Jun 23 2016 | EDGE | Edge Therapeutics, ... | Ratcliffe Liam | Director | Option Exercise | A | 9.34 | 30,000 | 280,200 | 30,000 | |
| Oct 25 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Option Exercise | A | 5.60 | 25,000 | 140,000 | 25,000 | |
| Sep 30 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Sell | S | 5.99 | 863,521 | 5,170,764 | 0 | 863.5 K to 0 (-100.00 %) |
| Sep 30 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Sell | S | 6.02 | 262,207 | 1,578,958 | 863,521 | 1.1 M to 863.5 K (-23.29 %) |
| Sep 16 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Sell | S | 6.14 | 319,033 | 1,957,650 | 1,125,728 | 1.4 M to 1.1 M (-22.08 %) |
| Sep 16 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Sell | S | 6.01 | 546,660 | 3,287,668 | 1,444,761 | 2 M to 1.4 M (-27.45 %) |
| Sep 16 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Sell | S | 6.10 | 807,479 | 4,923,119 | 1,991,421 | 2.8 M to 2 M (-28.85 %) |
| Sep 06 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Sell | S | 5.68 | 139,572 | 793,202 | 2,798,900 | 2.9 M to 2.8 M (-4.75 %) |
| Sep 06 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Sell | S | 5.77 | 201,598 | 1,163,523 | 2,938,472 | 3.1 M to 2.9 M (-6.42 %) |
| Sep 06 2013 | ARRY | ARRAY BIOPHARMA IN ... | Ratcliffe Liam | Director | Sell | S | 5.87 | 236,116 | 1,385,623 | 3,140,070 | 3.4 M to 3.1 M (-6.99 %) |
Page: 1